Global Drugs of Bioengineered Protein Market Growth, Trends, and Forecasts 2016-2026

April 2021 | 116 pages | ID: G56649F5F6BFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this latest study, the 2021 growth of Drugs of Bioengineered Protein will have significant change from previous year. By the most conservative estimates of global Drugs of Bioengineered Protein market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Drugs of Bioengineered Protein market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs of Bioengineered Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by product type

• Monoclonal Antibodies
• Therapeutic Proteins
• Vaccines

Segmentation by Application

• Endocrinology
• Immunology
• Hematology
• Infectiology
• Neurology
• Oncology
• Genetic Disorder

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• Rest of Americas
• APAC
• China
• Japan
• Korea
• Taiwan
• India
• Australia
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Rest of APAC
• Europe
• Germany
• France
• UK
• Russia
• Italy
• Benelux
• Nordic
• Rest of Europe
• MENA
• Saudi Arabia
• UAE
• Turkey
• South Africa
• Egypt
• Rest of MENA

The report also presents the market competition landscape and a corresponding detailed analysis of the major companies in the market.

• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Novartis
• Sanofi
• Eli Lilly
• Roche
• Dr. Reddy's Laboratories
• Abbott Laboratories
• Amgen
• Bayer AG
• Biocon
• Fresenius kabi
• Panacea Biotec

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Drugs of Bioengineered Protein Market Size and Forecast, 2016-2026
  2.1.2 Drugs of Bioengineered Protein Market Size and Forecast by Region, 2016 VS 2021 VS 2026
2.2 Global Drugs of Bioengineered Protein Market Size and Forecast by Regions, 2016-2026 ($ millions)
2.3 Americas Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
2.4 APAC Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
2.5 Europe Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
2.6 MENA Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)

3 DRUGS OF BIOENGINEERED PROTEIN MARKET SIZE BY PLAYER

3.1 Global Drugs of Bioengineered Protein Market Size by Player
  3.1.1 Global Top Players Drugs of Bioengineered Protein Revenue, 2019-2021E ($ millions)
  3.1.2 Global Top Drugs of Bioengineered Protein Players Market Share, 2019-2021E
3.2 Global Key Drugs of Bioengineered Protein Players Rank in 2020
3.3 Global Key Drugs of Bioengineered Protein Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
  3.4.1 Competition Landscape Analysis
  3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2019-2021E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion

4 DRUGS OF BIOENGINEERED PROTEIN SEGMENT BY TYPE

4.1 Overview
  4.1.1 Monoclonal Antibodies
  4.1.2 Therapeutic Proteins
  4.1.3 Vaccines
4.2 Global Drugs of Bioengineered Protein Market Size by Type, 2016-2026 ($ millions)
4.3 Monoclonal Antibodies Market Size by Region, 2016-2026 ($ millions)
4.4 Therapeutic Proteins Market Size by Region, 2016-2026 ($ millions)
4.5 Vaccines Market Size by Region, 2016-2026 ($ millions)

5 DRUGS OF BIOENGINEERED PROTEIN SEGMENT BY APPLICATION

5.1 Overview
  5.1.1 Endocrinology
  5.1.2 Immunology
  5.1.3 Hematology
  5.1.4 Infectiology
  5.1.5 Neurology
  5.1.6 Oncology
  5.1.7 Genetic Disorder
5.2 Global Drugs of Bioengineered Protein Market Size and Forecast by Application, 2016-2026
5.3 Endocrinology Market Size by Region, 2016-2026 ($ millions)
5.4 Immunology Market Size by Region, 2016-2026 ($ millions)
5.5 Hematology Market Size by Region, 2016-2026 ($ millions)
5.6 Infectiology Market Size by Region, 2016-2026 ($ millions)
5.7 Neurology Market Size by Region, 2016-2026 ($ millions)
5.8 Oncology Market Size by Region, 2016-2026 ($ millions)
5.9 Genetic Disorder Market Size by Region, 2016-2026 ($ millions)

6 AMERICAS

6.1 Americas Drugs of Bioengineered Protein Market Size by Country
6.2 United States Drugs of Bioengineered Protein Market Size
6.3 Canada Drugs of Bioengineered Protein Market Size
6.4 Mexico Drugs of Bioengineered Protein Market Size
6.5 Brazil Drugs of Bioengineered Protein Market Size

7 APAC

7.1 APAC Drugs of Bioengineered Protein Market Size by Region
7.2 China Drugs of Bioengineered Protein Market Size
7.3 Japan Drugs of Bioengineered Protein Market Size
7.4 Korea Drugs of Bioengineered Protein Market Size
7.5 Taiwan Drugs of Bioengineered Protein Market Size
7.6 India Drugs of Bioengineered Protein Market Size
7.7 Australia Drugs of Bioengineered Protein Market Size
7.8 Indonesia Drugs of Bioengineered Protein Market Size
7.9 Thailand Drugs of Bioengineered Protein Market Size
7.10 Malaysia Drugs of Bioengineered Protein Market Size
7.11 Philippines Drugs of Bioengineered Protein Market Size
7.12 Vietnam Drugs of Bioengineered Protein Market Size

8 EUROPE

8.1 Europe Drugs of Bioengineered Protein Market Size by Country
8.2 Germany Drugs of Bioengineered Protein Market Size
8.3 France Drugs of Bioengineered Protein Market Size
8.4 UK Drugs of Bioengineered Protein Market Size
8.5 Russia Drugs of Bioengineered Protein Market Size
8.6 Italy Drugs of Bioengineered Protein Market Size
8.7 Australia Drugs of Bioengineered Protein Market Size
8.8 Benelux Drugs of Bioengineered Protein Market Size
8.9 Nordic Drugs of Bioengineered Protein Market Size

9 MENA

9.1 MENA Drugs of Bioengineered Protein Market Size by Country
9.2 Saudi Arabia Drugs of Bioengineered Protein Market Size
9.3 UAE Drugs of Bioengineered Protein Market Size
9.4 Turkey Drugs of Bioengineered Protein Market Size
9.5 South Africa Drugs of Bioengineered Protein Market Size
9.6 Egypt Drugs of Bioengineered Protein Market Size

10 MARKET DRIVERS, CHALLENGES AND TRENDS

10.1 Market Drivers and Impact
  10.1.1 Growing Demand from Key Regions
  10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline Drugs of Bioengineered Protein Product Offered
  11.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Drugs of Bioengineered Protein Product Offered
  11.2.3 Johnson & Johnson Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 Merck
  11.3.1 Merck Company Information
  11.3.2 Merck Drugs of Bioengineered Protein Product Offered
  11.3.3 Merck Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.3.4 Merck Main Business Overview
  11.3.5 Merck Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Drugs of Bioengineered Protein Product Offered
  11.4.3 Novartis Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Drugs of Bioengineered Protein Product Offered
  11.5.3 Sanofi Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Eli Lilly
  11.6.1 Eli Lilly Company Information
  11.6.2 Eli Lilly Drugs of Bioengineered Protein Product Offered
  11.6.3 Eli Lilly Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.6.4 Eli Lilly Main Business Overview
  11.6.5 Eli Lilly Latest Developments
11.7 Roche
  11.7.1 Roche Company Information
  11.7.2 Roche Drugs of Bioengineered Protein Product Offered
  11.7.3 Roche Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.7.4 Roche Main Business Overview
  11.7.5 Roche Latest Developments
11.8 Dr. Reddy's Laboratories
  11.8.1 Dr. Reddy's Laboratories Company Information
  11.8.2 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product Offered
  11.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.8.4 Dr. Reddy's Laboratories Main Business Overview
  11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Abbott Laboratories
  11.9.1 Abbott Laboratories Company Information
  11.9.2 Abbott Laboratories Drugs of Bioengineered Protein Product Offered
  11.9.3 Abbott Laboratories Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.9.4 Abbott Laboratories Main Business Overview
  11.9.5 Abbott Laboratories Latest Developments
11.10 Amgen
  11.10.1 Amgen Company Information
  11.10.2 Amgen Drugs of Bioengineered Protein Product Offered
  11.10.3 Amgen Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.10.4 Amgen Main Business Overview
  11.10.5 Amgen Latest Developments
11.11 Bayer AG
  11.11.1 Bayer AG Company Information
  11.11.2 Bayer AG Drugs of Bioengineered Protein Product Offered
  11.11.3 Bayer AG Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.11.4 Bayer AG Main Business Overview
  11.11.5 Bayer AG Latest Developments
11.12 Biocon
  11.12.1 Biocon Company Information
  11.12.2 Biocon Drugs of Bioengineered Protein Product Offered
  11.12.3 Biocon Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.12.4 Biocon Main Business Overview
  11.12.5 Biocon Latest Developments
11.13 Fresenius kabi
  11.13.1 Fresenius kabi Company Information
  11.13.2 Fresenius kabi Drugs of Bioengineered Protein Product Offered
  11.13.3 Fresenius kabi Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.13.4 Fresenius kabi Main Business Overview
  11.13.5 Fresenius kabi Latest Developments
11.14 Panacea Biotec
  11.14.1 Panacea Biotec Company Information
  11.14.2 Panacea Biotec Drugs of Bioengineered Protein Product Offered
  11.14.3 Panacea Biotec Drugs of Bioengineered Protein Revenue and YoY Growth, 2019-2021E
  11.14.4 Panacea Biotec Main Business Overview
  11.14.5 Panacea Biotec Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Drugs of Bioengineered Protein Market Size CAGR by Region 2020-2026 ($ Millions)
Table 2. Global Drugs of Bioengineered Protein Market Size by Regions, 2016-2026 ($ millions)
Table 3. Global Drugs of Bioengineered Protein Market Size Share by Regions, 2016-2026
Table 4. Global Drugs of Bioengineered Protein Revenue by Player, 2019-2021E ($ millions)
Table 5. Global Drugs of Bioengineered Protein Revenue Market Share by Player, 2019-2021E
Table 6. Global Key Drugs of Bioengineered Protein Players Rank in 2020, Based on the Revenue in Drugs of Bioengineered Protein
Table 7. Global Key Drugs of Bioengineered Protein Players Head office and Products Offered
Table 8. Drugs of Bioengineered Protein Concentration Ratio (CR3, CR5 and CR10), 2019-2021E
Table 9. New Products and Potential Entrants
Table 10. Mergers & Acquisitions, Expansion
Table 11. Major Players of Monoclonal Antibodies
Table 12. Major Players of Therapeutic Proteins
Table 13. Major Players of Vaccines
Table 14. Global Drugs of Bioengineered Protein Market Size CAGR by Type ($ millions): 2016 VS 2021 VS 2026
Table 15. Global Drugs of Bioengineered Protein Market Size by Type, 2016-2026 ($ millions)
Table 16. Global Drugs of Bioengineered Protein Market Size Share by Type, 2016-2026
Table 17. Global Monoclonal Antibodies Market Size by Region, 2016-2026 ($ millions)
Table 18. Global Monoclonal Antibodies Market Size Share by Region, 2016-2026
Table 19. Global Therapeutic Proteins Market Size by Region, 2016-2026 ($ millions)
Table 20. Global Therapeutic Proteins Market Size Share by Region, 2016-2026
Table 21. Global Vaccines Market Size by Region, 2016-2026 ($ millions)
Table 22. Global Vaccines Market Size Share by Region, 2016-2026
Table 23. Drugs of Bioengineered Protein Market Size CAGR by Application ($ millions): 2016 VS 2021 VS 2026
Table 24. Global Drugs of Bioengineered Protein Market Size Forecast by Application, 2016-2026 ($ millions)
Table 25. Global Drugs of Bioengineered Protein Market Size Share Forecast by Application, 2016-2026
Table 26. Endocrinology Market Size by Region, 2016-2026 ($ millions)
Table 27. Endocrinology Market Size Share by Region, 2016-2026
Table 28. Immunology Market Size by Region, 2016-2026 ($ millions)
Table 29. Immunology Market Size Share by Region, 2016-2026
Table 30. Hematology Market Size by Region, 2016-2026 ($ millions)
Table 31. Hematology Market Size Share by Region, 2016-2026
Table 32. Infectiology Market Size by Region, 2016-2026 ($ millions)
Table 33. Infectiology Market Size Share by Region, 2016-2026
Table 34. Neurology Market Size by Region, 2016-2026 ($ millions)
Table 35. Neurology Market Size Share by Region, 2016-2026
Table 36. Oncology Market Size by Region, 2016-2026 ($ millions)
Table 37. Oncology Market Size Share by Region, 2016-2026
Table 38. Genetic Disorder Market Size by Region, 2016-2026 ($ millions)
Table 39. Genetic Disorder Market Size Share by Region, 2016-2026
Table 40. Americas Drugs of Bioengineered Protein Market Size by Country, 2016-2021 ($ Millions)
Table 41. Americas Drugs of Bioengineered Protein Market Size Share by Country, 2016-2021
Table 42. APAC Drugs of Bioengineered Protein Market Size by Region, 2016-2021 ($ Millions)
Table 43. APAC Drugs of Bioengineered Protein Market Size Share by Region, 2016-2021
Table 44. Europe Drugs of Bioengineered Protein Market Size by Country, 2016-2021 ($ Millions)
Table 45. Europe Drugs of Bioengineered Protein Market Size Share by Country, 2016-2021
Table 46. MENA Drugs of Bioengineered Protein Market Size by Country, 2016-2021 ($ Millions)
Table 47. MENA Drugs of Bioengineered Protein Market Size Share by Country, 2016-2021
Table 48. Key and Potential Regions of Drugs of Bioengineered Protein
Table 49. Key Application and Potential Industries of Drugs of Bioengineered Protein
Table 50. Key Challenges of Drugs of Bioengineered Protein
Table 51. Key Trends of Drugs of Bioengineered Protein
Table 52. GlaxoSmithKline Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 53. GlaxoSmithKline Drugs of Bioengineered Protein Product Offered
Table 54. GlaxoSmithKline Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. Johnson & Johnson Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 58. Johnson & Johnson Drugs of Bioengineered Protein Product Offered
Table 59. Johnson & Johnson Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Latest Developments
Table 62. Merck Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 63. Merck Drugs of Bioengineered Protein Product Offered
Table 64. Merck Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 65. Merck Main Business
Table 66. Merck Latest Developments
Table 67. Novartis Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 68. Novartis Drugs of Bioengineered Protein Product Offered
Table 69. Novartis Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 70. Novartis Main Business
Table 71. Novartis Latest Developments
Table 72. Sanofi Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 73. Sanofi Drugs of Bioengineered Protein Product Offered
Table 74. Sanofi Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. Eli Lilly Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 78. Eli Lilly Drugs of Bioengineered Protein Product Offered
Table 79. Eli Lilly Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. Roche Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 83. Roche Drugs of Bioengineered Protein Product Offered
Table 84. Roche Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. Dr. Reddy's Laboratories Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 88. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product Offered
Table 89. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 90. Dr. Reddy's Laboratories Main Business
Table 91. Dr. Reddy's Laboratories Latest Developments
Table 92. Abbott Laboratories Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 93. Abbott Laboratories Drugs of Bioengineered Protein Product Offered
Table 94. Abbott Laboratories Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. Amgen Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 98. Amgen Drugs of Bioengineered Protein Product Offered
Table 99. Amgen Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 100. Amgen Main Business
Table 101. Amgen Latest Developments
Table 102. Bayer AG Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 103. Bayer AG Drugs of Bioengineered Protein Product Offered
Table 104. Bayer AG Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Biocon Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 108. Biocon Drugs of Bioengineered Protein Product Offered
Table 109. Biocon Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 110. Biocon Main Business
Table 111. Biocon Latest Developments
Table 112. Fresenius kabi Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 113. Fresenius kabi Drugs of Bioengineered Protein Product Offered
Table 114. Fresenius kabi Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 115. Fresenius kabi Main Business
Table 116. Fresenius kabi Latest Developments
Table 117. Panacea Biotec Details, Head Office, Drugs of Bioengineered Protein Area Served and Its Competitors
Table 118. Panacea Biotec Drugs of Bioengineered Protein Product Offered
Table 119. Panacea Biotec Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2019-2021E
Table 120. Panacea Biotec Main Business
Table 121. Panacea Biotec Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Drugs of Bioengineered Protein Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs of Bioengineered Protein Market Size Growth Rate, 2016-2026 ($ millions)
Figure 6. Drugs of Bioengineered Protein Consumption by Region (2016 VS 2021 & 2026) ($ millions)
Figure 7. Global Drugs of Bioengineered Protein Market Size Share by Regions, 2016-2026
Figure 8. Americas Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 9. APAC Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 10. Europe Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 11. MENA Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 12. Global Drugs of Bioengineered Protein Revenue Market Share by Player in 2020
Figure 13. Global Drugs of Bioengineered Protein Market Size Share by Type in 2020
Figure 14. Drugs of Bioengineered Protein in Endocrinology
Figure 15. Global Drugs of Bioengineered Protein Market Size YoY Growth: Endocrinology, 2016-2026 ($ millions)
Figure 16. Drugs of Bioengineered Protein in Immunology
Figure 17. Global Drugs of Bioengineered Protein Market Size YoY Growth: Immunology, 2016-2026 ($ millions)
Figure 18. Drugs of Bioengineered Protein in Hematology
Figure 19. Global Drugs of Bioengineered Protein Market Size YoY Growth: Hematology, 2016-2026 ($ millions)
Figure 20. Drugs of Bioengineered Protein in Infectiology
Figure 21. Global Drugs of Bioengineered Protein Market Size YoY Growth: Infectiology, 2016-2026 ($ millions)
Figure 22. Drugs of Bioengineered Protein in Neurology
Figure 23. Global Drugs of Bioengineered Protein Market Size YoY Growth: Neurology, 2016-2026 ($ millions)
Figure 24. Drugs of Bioengineered Protein in Oncology
Figure 25. Global Drugs of Bioengineered Protein Market Size YoY Growth: Oncology, 2016-2026 ($ millions)
Figure 26. Drugs of Bioengineered Protein in Genetic Disorder
Figure 27. Global Drugs of Bioengineered Protein Market Size YoY Growth: Genetic Disorder, 2016-2026 ($ millions)
Figure 28. Americas Drugs of Bioengineered Protein Value Market Share by Country in 2020
Figure 29. Drugs of Bioengineered Protein Market Size in United States, 2016-2026 ($ millions)
Figure 30. Canada Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 31. Mexico Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 32. Brazil Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 33. China Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 34. Japan Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 35. Korea Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 36. Taiwan Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 37. India Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 38. Australia Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 39. Indonesia Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 40. Thailand Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 41. Malaysia Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 42. Philippines Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 43. Vietnam Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 44. Germany Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 45. France Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 46. UK Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 47. Russia Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 48. Italy Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 49. Australia Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 50. Benelux Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 51. Nordic Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 52. Saudi Arabia Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 53. UAE Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 54. Turkey Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 55. South Africa Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)
Figure 56. Egypt Drugs of Bioengineered Protein Market Size YoY Growth, 2016-2026 ($ millions)